April

Asthma, airway inflammation and epithelial damage in elite athletes Carlsen K-H. Eur Respir J 2009; 33: 713-714
Remember elephants and icebergs... "Your lung function should be here, but it is there!" Soriano J. B., Parkes G. Eur Respir J 2009; 33: 715-716
Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern Michelakis E. D. Eur Respir J 2009; 33: 717-721
Quality control: a necessary, but sometimes overlooked, tool for improving respiratory medicine Farre R., Navajas D. Eur Respir J 2009; 33: 722-723
Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults Kurt E., Metintas S., Basyigit I., Bulut I., Coskun E., Dabak S., Deveci F., Fidan F., Kaynar H., Uzaslan E.Kunt, Onbasi K., Ozkurt S., Karakis G.Pasaoglu, Sahan S., Sahin U., Oguzulgen K., Yildiz F., Mungan D., Yorgancioglu A., Gemicioglu B., A.Fuat Kalyoncu for the PARFAIT Study of the Turkish Thoracic Society Asthma, Allergy Working Group Eur Respir J 2009; 33: 724-733
Comparative airway response to high- versus low-molecular weight agents in occupational asthma Dufour M-H., Lemiere C., Prince P., Boulet L-P. Eur Respir J 2009; 33: 734-739
Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes Bougault V., Turmel J., St-Laurent J., Bertrand M., Boulet L-P. Eur Respir J 2009; 33: 740-746
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Dahlen B., Lantz A-S., Ihre E., Skedinger M., Henriksson E., Jorgensen L., Ekstrom T., Dahlen S-E., Larsson K. Eur Respir J 2009; 33: 747-753
Efficacy of confronting smokers with airflow limitation for smoking cessation Kotz D., Wesseling G., Huibers M. J. H., van Schayck O. C. P. Eur Respir J 2009; 33: 754-762
Relationship between ventilatory constraint and muscle fatigue during exercise in COPD Butcher S. J., Lagerquist O., Marciniuk D. D., Petersen S. R., Collins D. F., Jones, R. L. Eur Respir J 2009; 33: 763-770
Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD Mahler D. A., Murray J. A., Waterman L. A., Ward J., Kraemer W. J., Zhang, X., Baird, J. C. Eur Respir J 2009; 33: 771-777
Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD Perng D-W., Tao C-W., Su K-C., Tsai C-C., Liu, L-Y., Lee, Y-C. Eur Respir J 2009; 33: 778-784
First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension Grimminger F., Weimann G., Frey R., Voswinckel R., Thamm M., Bolkow D., Weissmann N., Muck W., Unger S., Wensing G., Schermuly R. T., Ghofrani H.A. Eur Respir J 2009; 33: 785-792
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Lederer D. J., Jelic S., Basner R. C., Ishizaka A., Bhattacharya J. Eur Respir J 2009; 33: 793-796
Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly Roche F., Gaspoz J-M., Pichot V., Picard-Kossovsky M., Maudoux D., Garcin A., Celle S., Sforza E., Barthelemy J. C., on behalf of the PROOF, SYNAPSE Study Groups Eur Respir J 2009; 33: 797-803
Compliance in sleep apnoea therapy: influence of home care support and pressure mode Damjanovic D., Fluck A., Bremer H., Muller-Quernheim J., Idzko M., Sorichter S. Eur Respir J 2009; 33: 804-811
Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice Kobashi Y., Sugiu T., Mouri K., Obase Y., Miyashita N., Oka M. Eur Respir J 2009; 33: 812-815
Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions Valdes L., San Jose E., Alvarez Dobano J. M., Golpe A., Valle J. M., Penela P., Gonzalez Barcala F. J. Eur Respir J 2009; 33: 816-820
Differential diagnosis and management of focal ground-glass opacities Infante M., Lutman R. F., Imparato S., Di Rocco M., Ceresoli G. L., Torri V., Morenghi E., Minuti F., Cavuto S., Bottoni E., Inzirillo F., Cariboni U., Errico V., Incarbone M. A., Ferraroli G., Brambilla G., Alloisio M., Ravasi G. Eur Respir J 2009; 33: 821-827
Quality control of DL,CO instruments in global clinical trials Jensen R., Leyk M., Crapo R., Muchmore D., Berclaz P. Y. Eur Respir J 2009; 33: 828-834
Cigarette smoke extract reduces VEGF in primary human airway epithelial cells Thaikoottathil J. V., Martin R. J., Zdunek J., Weinberger A., Rino J. G., Chu H. W. Eur Respir J 2009; 33: 835-843
Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions Ansell T. K., McFawn P. K., Noble P. B., West A. R., Fernandes L., Mitchell H. W. Eur Respir J 2009; 33: 844-851
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice Xu T., Qiao J., Zhao L., He G., Li K., Wang J., Tian Y., Wang H. Eur Respir J 2009; 33: 852-860
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia Woyda K., Koebrich S., Reiss I., Rudloff S., Pullamsetti S. S., Ruhlmann A., Weissmann N., Ghofrani H. A., Gunther A., Seeger W., Grimminger F., Morty R. E., Schermuly R. T. Eur Respir J 2009; 33: 861-870
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET Sotgiu G., Ferrara G., Matteelli A., Richardson M. D., Centis R., Ruesch-Gerdes S., Toungoussova O., Zellweger J-P., Spanevello A., Cirillo D., Lange C., Migliori G. B. Eur Respir J 2009; 33: 871-881
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement Antoniou K. M., Margaritopoulos G., Economidou F., Siafakas N. M. Eur Respir J 2009; 33: 882-896
Influence of comorbid conditions on asthma Boulet L-P. Eur Respir J 2009; 33: 897-906
Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing Jennum P., Riha R. L. Eur Respir J 2009; 33: 907-914
First- and second-line therapy for advanced nonsmall cell lung cancer Sculier J-P., Moro-Sibilot D. Eur Respir J 2009; 33: 915-930
Hypersensitivity pneumonitis associated with the use of temozolomide Koschel D., Handzhiev S., Leucht V., Holotiuk O., Fisseler-Eckhoff A., Hoffken G. Eur Respir J 2009; 33: 931-934
Infectious complications from full extension endobronchial ultrasound transbronchial needle aspiration Haas A. R. Eur Respir J 2009; 33: 935-938
Etanercept-induced pleuropericardial lupus-like syndrome Porfyridis I., Kalomenidis I., Psallidas I., Stratakos G., Roussos C., Vassilakopoulos T., Stathopoulos G. T. Eur Respir J 2009; 33: 939-941
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team Clifton I. J., Scarsbrook A. F., Muers M. F. Eur Respir J 2009; 33: 941-942
Smoking patterns in patients following a pulmonary embolism Klok F. A., Mos I. C. M., Tamsma J. T., van Kralingen K. W., Huisman M. V. Eur Respir J 2009; 33: 942-943
Poverty and tuberculosis: is it truly a simple inverse linear correlation? Marais B. J., Hesseling A. C., Cotton M. F. Eur Respir J 2009; 33: 943-944
Danger of using an unreliable classification system for preschool wheeze Schultz A., Payne D. Eur Respir J 2009; 33: 944-945
From the authors Bush A., Brand P. L. P. Eur Respir J 2009; 33: 945
The Greeks have a word for it Papagiannis A. Eur Respir J 2009; 33: 946
"PROGRESSION OF SNORING AND OBSTRUCTIVE SLEEP APNOEA: THE ROLE OF INCREASING WEIGHT AND TIME". G. BERGER, R. BERGER AND A. OKSENBERG. EUR RESPIR J 2009; 33: 338-345. Errata Eur Respir J 2009; 33: 947